Inaktiver Wert

Dendreon Corporation Aktie Nasdaq

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

La stratégie de Valeant saluée en Bourse	23.02.15
Endo : Drugmaker Valeant close to buying Salix - source	20.02.15
Dendreon : Valeant secures financing for potential Salix bid: Bloomberg	12.02.15
Dendreon : Valeant to buy Dendreon's prostate cancer vaccine Provenge	30.01.15

Sektor

	% 1. Jan.	Kap.
IQVIA HOLDINGS INC.	+1,51 %	42,75 Mrd.
LONZA GROUP AG	+49,22 %	41,61 Mrd.
MODERNA, INC.	+8,57 %	41,34 Mrd.
CELLTRION, INC.	-12,36 %	26,59 Mrd.
ICON PUBLIC LIMITED COMPANY	+8,92 %	25,49 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-25,13 %	18,12 Mrd.
MEDPACE HOLDINGS, INC.	+29,17 %	12,24 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12 %	11,76 Mrd.
UNITED THERAPEUTICS CORPORATION	+6,35 %	11 Mrd.